Cargando…

The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19

Detalles Bibliográficos
Autores principales:	Salem, Mohamed Labib, El-Hennawy, Dina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194943/ https://www.ncbi.nlm.nih.gov/pubmed/32361099 http://dx.doi.org/10.1016/j.mehy.2020.109752

Ejemplares similares

Exploring the possible use of saponin adjuvants in COVID-19 vaccine
por: Sharma, Rinku, et al.
Publicado: (2020)

Vitamin D as an Adjuvant Therapy in Neonatal Hypoxia: Is it Beneficial?
por: Hagag, Adel A., et al.
Publicado: (2019)

Possible effect of epinephrine in minimizing COVID-19 severity: a review
por: Derakhshan, Mahnaz, et al.
Publicado: (2020)

Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks
por: Liu, Chun G, et al.
Publicado: (2011)

Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate
por: Sisteré-Oró, Marta, et al.
Publicado: (2020)

Adjuvanted influenza vaccine dynamics
por: Parra-Rojas, César, et al.
Publicado: (2019)

Advances in Adjuvanted Influenza Vaccines
por: Shichinohe, Shintaro, et al.
Publicado: (2023)

Routine childhood immunization may protect against COVID-19
por: Salman, Samar, et al.
Publicado: (2020)

Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients
por: Yiğenoğlu, Tuğçe Nur, et al.
Publicado: (2021)

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES
por: Friedewald, William F.
Publicado: (1944)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
por: Lu, Lu, et al.
Publicado: (2020)

The Impact of Adjuvanted Influenza Vaccine on Disease Severity in the US: A Stochastic Model
por: Pelton, Stephen I., et al.
Publicado: (2023)

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines
por: Yoshino, Naoto, et al.
Publicado: (2023)

Adjuvants for COVID-19 Vaccines
por: Castrodeza-Sanz, Javier, et al.
Publicado: (2023)

BCG vaccination and the risk of COVID 19: A possible correlation
por: Ahmed, Sara M., et al.
Publicado: (2022)

Is COVID-19 vaccination beneficial or harmful to endothelial cells?
por: Mogi, Masaki
Publicado: (2022)

Near-Infrared Laser Adjuvant for Influenza Vaccine
por: Kashiwagi, Satoshi, et al.
Publicado: (2013)

Injectable Excipients as Novel Influenza Vaccine Adjuvants
por: Feng, Huapeng, et al.
Publicado: (2019)

Food Additives as Novel Influenza Vaccine Adjuvants
por: Feng, Huapeng, et al.
Publicado: (2019)

Promising Adjuvants and Platforms for Influenza Vaccine Development
por: Zhu, Wandi, et al.
Publicado: (2021)

Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications
por: Boikos, Constantina, et al.
Publicado: (2021)

Unintended beneficial effects of COVID-19 on influenza-associated emergency department use in Korea
por: Kim, Sola, et al.
Publicado: (2022)

Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis
por: Blaser, Cornelia, et al.
Publicado: (2010)

Possible Triggering Effect of Influenza Vaccination on Psoriasis
por: Gunes, Ali Tahsin, et al.
Publicado: (2015)

Impact of the influenza vaccine on COVID-19 infection rates and severity
por: Conlon, Anna, et al.
Publicado: (2021)

Atypical Antipsychotic Lumateperone Effects on the Adrenal Gland With Possible Beneficial Effect of Quercetin Co-administration
por: El-Haroun, Hala, et al.
Publicado: (2021)

Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
por: Mannino, Salvatore, et al.
Publicado: (2012)

The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
por: Kohli, Michele A., et al.
Publicado: (2021)

The role of adjuvant immunomodulatory agents for treatment of severe influenza
por: Hui, David S., et al.
Publicado: (2018)

An Economic Comparison in the Elderly of Adjuvanted Quadrivalent Influenza Vaccine with Recombinant Quadrivalent Influenza Vaccine in Spain
por: Ruiz-Aragón, Jesús, et al.
Publicado: (2023)

Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination
por: Karlsson, Erik A., et al.
Publicado: (2016)

AS03- and MF59-Adjuvanted Influenza Vaccines in Children
por: Wilkins, Amanda L., et al.
Publicado: (2017)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
por: Yin, Yinyan, et al.
Publicado: (2021)

Selenium supplementation has beneficial and detrimental effects on immunity to influenza vaccine in older adults
por: Ivory, Kamal, et al.
Publicado: (2017)

The Effect of Combining the COVID-19 Vaccine with the Seasonal Influenza Vaccine on Reducing COVID-19 Vaccine Rejection Among Libyans
por: Ghazy, Ramy Mohamed, et al.
Publicado: (2023)

Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States
por: Boikos, Constantina, et al.
Publicado: (2022)

A cross-sectional study from Qatar on the effect of influenza vaccination on the severity of COVID-19
por: Thomas, Merlin, et al.
Publicado: (2023)

Development of a minimal saponin vaccine adjuvant based on QS-21
por: Fernández-Tejada, Alberto, et al.
Publicado: (2014)

Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19
por: Orienti, Isabella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oorpj75jgbqh7nbg4l6n504hc7